{
    "organizations": [],
    "uuid": "9c379db9eb638ea49bdea99a4e4fc92b4345b472",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sophiris-bio-reports-q1-loss-per-s/brief-sophiris-bio-reports-q1-loss-per-share-0-11-idUSASC0A21K",
    "ord_in_thread": 0,
    "title": "BRIEF-Sophiris Bio Reports Q1 Loss Per Share $0.11",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 14 (Reuters) - Sophiris Bio Inc:\n* SOPHIRIS BIO REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS AND KEY CORPORATE HIGHLIGHTS\n* Q1 LOSS PER SHARE $0.11 * SOPHIRIS BIO - EXPECTS CASH AND CASH EQUIVALENTS WILL BE SUFFICIENT TO FUND OPERATIONS TO MIDDLE OF 2019, ASSUMING NO NEW CLINICAL TRIALS ARE INITIATED\n* AT MARCH 31, 2018, CO HAD CASH, CASH EQUIVALENTS AND SECURITIES AVAILABLE-FOR-SALE OF $22.1 MILLION AND WORKING CAPITAL OF $19.2 MILLION Source text for Eikon: Further company coverage:\nOur Standards: The Thomson Reuters Trust Principles. 0 : 0 narrow-browser-and-phone medium-browser-and-portrait-tablet landscape-tablet medium-wide-browser wide-browser-and-larger medium-browser-and-landscape-tablet medium-wide-browser-and-larger above-phone portrait-tablet-and-above above-portrait-tablet landscape-tablet-and-above landscape-tablet-and-medium-wide-browser portrait-tablet-and-below landscape-tablet-and-below Apps Newsletters Reuters Plus Advertising Guidelines Cookies Terms of Use Privacy\nAll Quote: s delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.\nÂ© 2018 Reuters. All Rights Reserved.",
    "published": "2018-05-15T04:13:00.000+03:00",
    "crawled": "2018-05-15T14:00:43.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sophiris",
        "bio",
        "inc",
        "sophiris",
        "bio",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "key",
        "corporate",
        "highlight",
        "q1",
        "loss",
        "per",
        "share",
        "sophiris",
        "bio",
        "expects",
        "cash",
        "cash",
        "equivalent",
        "sufficient",
        "fund",
        "operation",
        "middle",
        "assuming",
        "new",
        "clinical",
        "trial",
        "initiated",
        "march",
        "co",
        "cash",
        "cash",
        "equivalent",
        "security",
        "million",
        "working",
        "capital",
        "million",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "standard",
        "thomson",
        "reuters",
        "trust",
        "principle",
        "apps",
        "newsletter",
        "reuters",
        "plus",
        "advertising",
        "guideline",
        "cooky",
        "term",
        "use",
        "privacy",
        "quote",
        "delayed",
        "minimum",
        "minute",
        "see",
        "complete",
        "list",
        "exchange",
        "delay",
        "reuters",
        "right",
        "reserved"
    ]
}